NewsAAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food AllergyHealthDay.comMarch 6, 2026
NewsAAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for OsteoporosisHealthDay.comMarch 6, 2026
NewsSubset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based ChemoimmunotherapyHealthDay.comMarch 6, 2026
NewsLargest Operator of Nursing Homes in U.S. Issues Vaccine Mandate for All WorkersHealthDay.comAugust 5, 2021
